Clinical reasoning: cerebral cavernous malformations.
Chahine
Lama M
LM
chahinl@ccf.org
Berg
Michel J
MJ
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000473:pathology; D002536:Cerebral Arteries / Q000002:abnormalities / Q000473:pathology / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D054022:Cerebrum / Q000473:pathology* / Q000503:physiopathology; D003937:Diagnosis, Differential; D042783:Endothelial Cells / Q000473:pathology; D004827:Epilepsy / Q000209:etiology*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005911:Gliosis / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D020786:Hemangioma, Cavernous, Central Nervous System / Q000150:complications* / Q000235:genetics / Q000473:pathology*; D006485:Hemosiderin / Q000378:metabolism; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic
D000927:Anticonvulsants; D006485:Hemosiderin